1st Department of Obstetrics & Gynecology, Papageorgiou General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece (all authors)..
1st Department of Obstetrics & Gynecology, Papageorgiou General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece (all authors).
J Minim Invasive Gynecol. 2020 Feb;27(2):309-331.e3. doi: 10.1016/j.jmig.2019.08.004. Epub 2019 Aug 6.
The purpose of this systematic review was to identify the operative issues and specific dysmenorrhea and menorrhagia outcomes in women who had undergone fertility-sparing surgery, as well as determine the expected outcome for extirpative surgery.
PROSPERO (ID no. 125692). Search was conducted for eligible studies up to March 31, 2019, on MEDLINE/PubMed (1966-2019), Scopus/Elsevier (1950-2019), and Google Scholar (up to 2019). The search terms applied for the search strategy were as follows: adenomyosis, adenomyomas, uterus-sparing surgery, fertility-sparing surgery, pain, dysmenorrhea, menorrhagia, uterine volume, adenomyotic volume, case-control studies, cohort studies, and prospective studies.
A total of 443 studies were initially identified. Exclusion criteria was as follows: (1) inadequate description of preoperative adenomyosis or absence of postoperative histology confirmation of adenomyosis, (2) no statement of use of a standardized instrument for measurement of pain, bleeding, or adenomyotic/uterine volume, (3) follow-up <12 months postoperatively, (4) study population <20 women, and (5) non-English language.
TABULATION, INTEGRATION, AND RESULTS: Nineteen studies with a total of 1843 patients with adenomyosis were included. Twelve studies were further analyzed in the meta-analysis. Complete excision of adenomyosis was associated with improvement in pain, menorrhagia, and reduction of uterine volume by a factor of 6.2, 3.9, and 2.3, respectively; the partial excision of adenomyosis was associated with improvement in pain, menorrhagia, and reduction of uterine volume by a factor of 5.9, 3.0, and 2.9, respectively; the studies with a mixed volume of patients with complete and partial excision of adenomyosis reported improvement in pain, menorrhagia, and reduction of uterine volume by a factor of 4.0, 6.3, and 5.1, respectively.
The surgical treatment of adenomyosis results in the satisfactory control of pain and bleeding, as well as in the reduction of uterine volume. Further research is warranted to investigate the long-term control of symptoms to identify any parameters related to the recurrence of adenomyosis, as well as to compare the conservative surgical treatment of adenomyosis with other treatment options.
本系统评价旨在确定行保留生育功能手术的患者术中相关问题及具体痛经和月经过多结局,并确定子宫切除术的预期结局。
PROSPERO(注册号 125692)。截至 2019 年 3 月 31 日,我们在 MEDLINE/PubMed(1966-2019 年)、Scopus/Elsevier(1950-2019 年)和 Google Scholar(截至 2019 年)上进行了合格研究的检索。搜索策略中应用的检索词如下:子宫腺肌病、子宫腺肌瘤、保留子宫手术、保留生育功能手术、疼痛、痛经、月经过多、子宫体积、子宫腺肌瘤体积、病例对照研究、队列研究和前瞻性研究。
最初共确定了 443 项研究。排除标准如下:(1)术前子宫腺肌病描述不充分或术后无组织学证实存在子宫腺肌病,(2)未说明使用标准化仪器测量疼痛、出血或子宫腺肌病/子宫体积,(3)术后随访<12 个月,(4)研究人群<20 名女性,(5)非英语语言。
列表、综合和结果:纳入了 19 项共 1843 例子宫腺肌病患者的研究。对 12 项研究进行了荟萃分析。子宫腺肌病的完全切除与疼痛、月经过多和子宫体积减少分别相关,其相关系数分别为 6.2、3.9 和 2.3;子宫腺肌病的部分切除与疼痛、月经过多和子宫体积减少相关,其相关系数分别为 5.9、3.0 和 2.9;同时包含完全切除和部分切除子宫腺肌病患者的研究报告称,疼痛、月经过多和子宫体积减少的相关系数分别为 4.0、6.3 和 5.1。
子宫腺肌病的手术治疗可满意控制疼痛和出血,并减少子宫体积。需要进一步研究以探讨症状的长期控制,以确定与子宫腺肌病复发相关的任何参数,并比较子宫腺肌病的保守手术治疗与其他治疗选择。